Global Market Research Group

Press Release – 18 Jan 2019 Research and Development News -- . . Latest Update "Dengue Vaccine Market: Contribution of NGOs for Better Vaccine Access Expected to Drive the Market in Lower Income Countries: Global Industry Analysis & Opportunity Assessment, 2017 - 2027" with Industries Survey | Global Current Growth and Future. ' ' “Global dengue vaccine market revenue is expected to expand at a significant rate owing to a large unmet need” The first dengue vaccine, Dengvaxia (CYD-TDV) developed by Sanofi Pasteur is registered in 14 countries in the Latin America and Asia Pacific region. CYD-TDV vaccine is a live recombinant tetravalent dengue vaccine that is indicated as a 3 dose series of 0/6/12 month schedule. There are around five other vaccine candidates under evaluation in clinical trials, comprising other live-attenuated vaccines as well as subunit, DNA and purified inactivated vaccine candidates of which Takedas TAK-003 and Butantan Institute

"Global Dengue Vaccine Industry 2018, Trends and Forecast Report" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. . . Description- ' ' Dengue Vaccine Market Report by Material, Application, and Geography Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). . . Get Sample Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=1494962 ' ' The report firstly introduced the Dengue Vaccine basics: definitions, classifications, applications and market overview; product specific